Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.
Francis Medical today announced the first commercial procedure using its Vanquish water vapor ablation system.
News-Medical.Net on MSN
Novel laser focal therapy device shows promising results for prostate cancer treatment
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...
MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...
Ivanhoe on MSN
Options for prostate cancer
ORLANDO, Fla. (Ivanhoe Newswire) — The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is ...
Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results